Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Rheumatology (Oxford, England)|October 2, 2010
Intensive lipid lowering in patients with rheumatoid arthritis and previous myocardial infarction: an explorative analysis from the incremental decrease in endpoints through aggressive lipid lowering (IDEAL) trialAnne G Semb, Ingar Holme, Tore K Kvien, et al.
Arthritis Care & Research|September 23, 2018
Left Ventricular Systolic Myocardial Function in Ankylosing SpondylitisHelga Midtbø, Anne G Semb, Knut Matre, et al.
The Cochrane Database of Systematic Reviews|September 3, 2019
Smoking cessation intervention for reducing disease activity in chronic autoimmune inflammatory joint diseasesIda K Roelsgaard, Bente A Esbensen, Mikkel Østergaard, et al.
Rheumatology International|February 24, 2020
Strategies for implementation of guideline recommended cardiovascular risk management for patients with rheumatoid arthritis: results from a questionnaire survey of expert rheumatology centersJulia M Weijers, Anne G Semb, Silvia Rollefstad, et al.
Physical Therapy|November 19, 2011
Physical fitness in patients with ankylosing spondylitis: comparison with population controlsSilje Halvorsen, Nina K Vøllestad, Camilla Fongen, et al.
The Journal of Rheumatology|January 17, 2013
Carotid plaque characteristics and disease activity in rheumatoid arthritisAnne G Semb, Silvia Rollefstad, Sella A Provan, et al.
Circulation|March 31, 2004
Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of HMG-CoA reductase inhibitorsTorgun Waehre, Arne Yndestad, Camilla Smith, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 28, 2009
Osteoprotegerin and soluble receptor activator of nuclear factor-kappaB ligand and risk for coronary events: a nested case-control approach in the prospective EPIC-Norfolk population study 1993-2003Anne G Semb, Thor Ueland, Pål Aukrust, et al.
Journal of the American College of Cardiology|May 14, 2003
Hydroxymethylglutaryl coenzyme a reductase inhibitors down-regulate chemokines and chemokine receptors in patients with coronary artery diseaseTorgun Waehre, Jan K Damås, Lars Gullestad, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 29, 2005
Chemokines in children with heterozygous familiar hypercholesterolemia: selective upregulation of RANTESKirsten B Holven, Jan K Damås, Arne Yndestad, et al.
Pageof 2